WO2007112286A3 - Stabilized compositions containing alkaline labile drugs - Google Patents
Stabilized compositions containing alkaline labile drugs Download PDFInfo
- Publication number
- WO2007112286A3 WO2007112286A3 PCT/US2007/064714 US2007064714W WO2007112286A3 WO 2007112286 A3 WO2007112286 A3 WO 2007112286A3 US 2007064714 W US2007064714 W US 2007064714W WO 2007112286 A3 WO2007112286 A3 WO 2007112286A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- excipient mixture
- hot
- alkaline labile
- hme
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
Abstract
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/294,367 US8173152B2 (en) | 2006-03-24 | 2007-03-22 | Stabilized compositions containing alkaline labile drugs |
JP2009503173A JP5536446B2 (en) | 2006-03-24 | 2007-03-22 | Stabilized composition comprising an alkali labile drug |
CA2647809A CA2647809C (en) | 2006-03-24 | 2007-03-22 | Stabilized compositions containing alkaline labile drugs |
CN2007800188470A CN101484142B (en) | 2006-03-24 | 2007-03-22 | Stabilized compositions containing alkaline labile drugs |
AU2007230730A AU2007230730B2 (en) | 2006-03-24 | 2007-03-22 | Stabilized compositions containing alkaline labile drugs |
MX2008012264A MX2008012264A (en) | 2006-03-24 | 2007-03-22 | Stabilized compositions containing alkaline labile drugs. |
NZ572207A NZ572207A (en) | 2006-03-24 | 2007-03-22 | Stabilized compositions containing alkaline labile drugs |
EP07759188.1A EP2010156B1 (en) | 2006-03-24 | 2007-03-22 | Stabilized compositions containing alkaline labile drugs |
BRPI0709148-6A BRPI0709148A2 (en) | 2006-03-24 | 2007-03-22 | stabilized compositions containing labile alkaline drugs |
ES07759188.1T ES2619906T3 (en) | 2006-03-24 | 2007-03-22 | Stabilized compositions containing alkaline labile drugs |
IL194222A IL194222A (en) | 2006-03-24 | 2008-09-21 | Process for preparing a stabilized, bioadhesive hot-melt extruded composition containing a mixture of excipients having a ph less than 7 that are mixed prior to being mixed with an alkaline labile drug |
ZA2008/09104A ZA200809104B (en) | 2006-03-24 | 2008-10-23 | Staboilized compositions containing alkaline labile drugs |
US13/463,375 US8883187B2 (en) | 2006-03-24 | 2012-05-03 | Stabilized compositions containing alkaline labile drugs |
US14/517,140 US9364445B2 (en) | 2006-03-24 | 2014-10-17 | Stabilized compositions containing alkaline labile drugs |
US15/159,285 US9867786B2 (en) | 2006-03-24 | 2016-05-19 | Stabilized compositions containing alkaline labile drugs |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78550506P | 2006-03-24 | 2006-03-24 | |
US60/785,505 | 2006-03-24 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/294,367 A-371-Of-International US8173152B2 (en) | 2006-03-24 | 2007-03-22 | Stabilized compositions containing alkaline labile drugs |
US13/463,375 Division US8883187B2 (en) | 2006-03-24 | 2012-05-03 | Stabilized compositions containing alkaline labile drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007112286A2 WO2007112286A2 (en) | 2007-10-04 |
WO2007112286A3 true WO2007112286A3 (en) | 2008-05-15 |
Family
ID=38541815
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/064714 WO2007112286A2 (en) | 2006-03-24 | 2007-03-22 | Stabilized compositions containing alkaline labile drugs |
Country Status (13)
Country | Link |
---|---|
US (4) | US8173152B2 (en) |
EP (2) | EP2010156B1 (en) |
JP (1) | JP5536446B2 (en) |
CN (1) | CN101484142B (en) |
AU (1) | AU2007230730B2 (en) |
BR (1) | BRPI0709148A2 (en) |
CA (2) | CA2647809C (en) |
ES (1) | ES2619906T3 (en) |
IL (1) | IL194222A (en) |
MX (1) | MX2008012264A (en) |
NZ (1) | NZ572207A (en) |
WO (1) | WO2007112286A2 (en) |
ZA (1) | ZA200809104B (en) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040253310A1 (en) | 2001-09-21 | 2004-12-16 | Gina Fischer | Morphine polymer release system |
WO2003024429A1 (en) | 2001-09-21 | 2003-03-27 | Egalet A/S | Polymer release system |
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
EP1610767B1 (en) | 2003-03-26 | 2011-01-19 | Egalet A/S | Morphine controlled release system |
DE102005005446A1 (en) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Break-resistant dosage forms with sustained release |
DE10336400A1 (en) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Anti-abuse dosage form |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
DE10361596A1 (en) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Process for producing an anti-abuse dosage form |
DE102004032049A1 (en) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Anti-abuse, oral dosage form |
DE102005005449A1 (en) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Process for producing an anti-abuse dosage form |
MX2008012264A (en) * | 2006-03-24 | 2009-02-20 | Auxilium Int Holdings Inc | Stabilized compositions containing alkaline labile drugs. |
CA2687192C (en) | 2007-06-04 | 2015-11-24 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
RU2493830C2 (en) | 2008-01-25 | 2013-09-27 | Грюненталь Гмбх | Drug form |
US9107815B2 (en) | 2008-02-22 | 2015-08-18 | Allergan, Inc. | Sustained release poloxamer containing pharmaceutical compositions |
AU2009243681B2 (en) | 2008-05-09 | 2013-12-19 | Grunenthal Gmbh | Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step |
WO2010033540A1 (en) * | 2008-09-19 | 2010-03-25 | Mallinckrodt Inc. | Crystalline forms of fentanyl alkaloid |
WO2010089132A1 (en) | 2009-02-06 | 2010-08-12 | Egalet A/S | Immediate release composition resistant to abuse by intake of alcohol |
EP2445487A2 (en) | 2009-06-24 | 2012-05-02 | Egalet Ltd. | Controlled release formulations |
EP2997965B1 (en) | 2009-07-22 | 2019-01-02 | Grünenthal GmbH | Tamper-resistant dosage form for oxidation-sensitive opioids |
PL2456427T3 (en) | 2009-07-22 | 2015-07-31 | Gruenenthal Gmbh | Hot-melt extruded controlled release dosage form |
ES2606227T3 (en) | 2010-02-03 | 2017-03-23 | Grünenthal GmbH | Preparation of a pharmaceutical powder composition by an extruder |
WO2011119287A1 (en) * | 2010-03-26 | 2011-09-29 | Dow Global Technologies Llc | Melt-extruded film |
US9572773B2 (en) * | 2010-04-26 | 2017-02-21 | Novartis A.G. | Layered drug delivery device |
JP2012031164A (en) * | 2010-07-06 | 2012-02-16 | Teika Seiyaku Kk | Film-shaped preparation |
TWI516286B (en) | 2010-09-02 | 2016-01-11 | 歌林達股份有限公司 | Tamper resistant dosage form comprising an anionic polymer |
MX2013002377A (en) | 2010-09-02 | 2013-04-29 | Gruenenthal Gmbh | Tamper resistant dosage form comprising inorganic salt. |
BR112013017311A2 (en) * | 2011-01-07 | 2016-10-04 | Revance Therapeutics Inc | methods and kits for topical application, removal and inactivation of therapeutic or cosmetic toxin compositions |
WO2012120364A2 (en) * | 2011-03-09 | 2012-09-13 | Ideal Cures Pvt. Ltd. | Novel immediate release film coating compositions |
BR112014001091A2 (en) | 2011-07-29 | 2017-02-14 | Gruenenthal Gmbh | tamper resistant tablet that provides immediate release of the drug |
LT2736495T (en) | 2011-07-29 | 2017-11-10 | Grünenthal GmbH | Tamper-resistant tablet providing immediate drug release |
KR101156054B1 (en) * | 2011-09-05 | 2012-06-20 | 주식회사 네비팜 | A stable and control-released pharmaceutical composition comprising eperisone |
US9440377B2 (en) * | 2012-01-25 | 2016-09-13 | Assa Abloy Ab | Functional laminate warp elimination method |
BR112014019988A8 (en) | 2012-02-28 | 2017-07-11 | Gruenenthal Gmbh | BREAK-RESISTANT DOSAGE FORM COMPRISING A PHARMACOLOGICALLY ACTIVE COMPOUND AND AN ANIONIC POLYMER |
WO2013150542A2 (en) * | 2012-04-05 | 2013-10-10 | Sparsha Pharma International Private Limited | A transdermal patch for treatment of dementia or alzheimer type dementia |
AR090695A1 (en) | 2012-04-18 | 2014-12-03 | Gruenenthal Gmbh | PHARMACEUTICAL DOSAGE FORM RESISTANT TO ADULTERATION AND RESISTANT TO IMMEDIATE RELEASE OF DOSE |
WO2013158814A1 (en) | 2012-04-18 | 2013-10-24 | Mallinckrodt Llc | Immediate release, abuse deterrent pharmaceutical compositions |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
KR20150059167A (en) | 2012-07-06 | 2015-05-29 | 에갈렛 리미티드 | Abuse deterrent pharmaceutical compositions for controlled release |
PL2872121T3 (en) | 2012-07-12 | 2019-02-28 | SpecGx LLC | Extended release, abuse deterrent pharmaceutical compositions |
WO2014065870A1 (en) * | 2012-10-22 | 2014-05-01 | Stc.Unm | Bioadhesive films for local and/or systemic delivery |
JP6255474B2 (en) | 2013-03-15 | 2017-12-27 | マリンクロッド エルエルシー | Abuse deterrent solid dosage form for immediate release with functional secant |
JP6466417B2 (en) | 2013-05-29 | 2019-02-06 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | A tamper-resistant dosage form with a bimodal release profile |
CA2907950A1 (en) | 2013-05-29 | 2014-12-04 | Grunenthal Gmbh | Tamper-resistant dosage form containing one or more particles |
MX368846B (en) | 2013-07-12 | 2019-10-18 | Gruenenthal Gmbh | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer. |
CA2931553C (en) | 2013-11-26 | 2022-01-18 | Grunenthal Gmbh | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
EP2889030A1 (en) * | 2013-12-30 | 2015-07-01 | Uluru Inc. | Controlling the erosion rates of mucoadhesive devices that deliver actives and other compounds and providing increased and variable therapeutic blood levels |
CA2947786A1 (en) | 2014-05-12 | 2015-11-19 | Grunenthal Gmbh | Tamper resistant immediate release capsule formulation comprising tapentadol |
EP3148512A1 (en) | 2014-05-26 | 2017-04-05 | Grünenthal GmbH | Multiparticles safeguarded against ethanolic dose-dumping |
EP3164117B1 (en) | 2014-07-03 | 2023-09-06 | SpecGx LLC | Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides |
GB201502077D0 (en) * | 2015-02-09 | 2015-03-25 | Cubic Pharmaceuticals Ltd And Delta Pharmaceuticals Ltd | Improved hme technology |
EP3285745A1 (en) | 2015-04-24 | 2018-02-28 | Grünenthal GmbH | Tamper-resistant dosage form with immediate release and resistance against solvent extraction |
JP6938462B2 (en) * | 2015-07-28 | 2021-09-22 | ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System | Implant composition for unidirectional delivery of therapeutic compounds to the brain |
JP2018526414A (en) | 2015-09-10 | 2018-09-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | Protection against oral overdose with abuse-inhibiting immediate release formulations |
CA3013321A1 (en) | 2016-02-08 | 2017-08-17 | SpecGx LLC | Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties |
WO2018215994A1 (en) | 2017-05-26 | 2018-11-29 | Church & Dwight Co., Inc. | Oral care composition |
CN107718818B (en) * | 2017-11-30 | 2023-08-22 | 杭州瑞健科技有限公司 | Single-layer plastic large card for rapid diagnosis and manufacturing method and equipment thereof |
CN112739383B (en) * | 2018-09-19 | 2024-03-15 | 埃斯普投资有限公司 | Peroxide-stable polymer compositions, process for their preparation and their use |
MX2021002459A (en) | 2018-09-25 | 2021-04-29 | SpecGx LLC | Abuse deterrent immediate release capsule dosage forms. |
CN109674758A (en) * | 2019-02-25 | 2019-04-26 | 湖南博隽生物医药有限公司 | A kind of Divalproex sodium sustained-release tablet and preparation method thereof for treating epilepsy |
CN109846604B (en) * | 2019-03-12 | 2021-04-06 | 广州中大药物开发有限公司 | Intelligent sanitary pad and preparation method thereof |
MX2021016044A (en) * | 2019-06-18 | 2022-04-06 | Dichlorphenamide compositions and methods of use. | |
WO2023150345A1 (en) * | 2022-02-04 | 2023-08-10 | Intact Therapeutics, Inc. | Mesalamine pharmaceutical formulations and methods of use thereof |
US20230312885A1 (en) * | 2022-03-11 | 2023-10-05 | Celanese International Corporation | Cellulose Ester Polymer Product With Increased Melt Flow Rate |
CN115606617B (en) * | 2022-09-27 | 2023-08-22 | 四川旅游学院 | Preparation method of Sichuan sausage capable of controlling nitrosamine content and improving shelf life |
CN116509823B (en) * | 2023-05-01 | 2024-02-13 | 长沙晶易医药科技股份有限公司 | Ketorolac tromethamine gel plaster composition, gel plaster and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6048547A (en) * | 1996-04-15 | 2000-04-11 | Seth; Pawan | Process for manufacturing solid compositions containing polyethylene oxide and an active ingredient |
US6375963B1 (en) * | 1999-06-16 | 2002-04-23 | Michael A. Repka | Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof |
US6649186B1 (en) * | 1996-09-20 | 2003-11-18 | Ethypharm | Effervescent granules and methods for their preparation |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3017304A (en) | 1956-05-24 | 1962-01-16 | Personal Products Corp | Absorbent fibrous structure and method of production |
US5318717A (en) | 1984-12-28 | 1994-06-07 | Alcon Laboratories, Inc. | Use of nonionic surfactant to enhance the cleaning effect of pancreatin on contact lenses |
USRE33093E (en) * | 1986-06-16 | 1989-10-17 | Johnson & Johnson Consumer Products, Inc. | Bioadhesive extruded film for intra-oral drug delivery and process |
US4713243A (en) * | 1986-06-16 | 1987-12-15 | Johnson & Johnson Products, Inc. | Bioadhesive extruded film for intra-oral drug delivery and process |
EP0437451B1 (en) | 1988-10-05 | 1993-06-09 | The Upjohn Company | Finely divided solid crystalline powders via precipitation into an anti-solvent |
CA2042452A1 (en) | 1990-05-25 | 1991-11-26 | Loren D. Trabert | Modified acrylic capstock |
US5095619A (en) | 1990-09-28 | 1992-03-17 | The Gillette Company | Shaving system |
BR9206408A (en) | 1991-08-23 | 1994-11-22 | Gillette Canada | Oral brush, extended release matrix, process for releasing an antimicrobial agent from an oral brush and for releasing an antimicrobial agent in an animal's mouth and an oral wear indicator brush |
US6010715A (en) | 1992-04-01 | 2000-01-04 | Bertek, Inc. | Transdermal patch incorporating a polymer film incorporated with an active agent |
CA2075517C (en) | 1992-04-01 | 1997-03-11 | John Wick | Transdermal patch incorporating a polymer film incorporated with an active agent |
US5614223A (en) | 1992-05-04 | 1997-03-25 | Digestive Care Inc. | Intraoral medicament-releasing device |
CA2169729C (en) | 1993-08-19 | 2001-04-03 | James E. Biegajski | Water-soluble pressure-sensitive mucoadhesive |
DE19504832A1 (en) | 1995-02-14 | 1996-08-22 | Basf Ag | Solid drug preparations |
US5766620A (en) | 1995-10-23 | 1998-06-16 | Theratech, Inc. | Buccal delivery of glucagon-like insulinotropic peptides |
US5874029A (en) | 1996-10-09 | 1999-02-23 | The University Of Kansas | Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent |
US6071539A (en) | 1996-09-20 | 2000-06-06 | Ethypharm, Sa | Effervescent granules and methods for their preparation |
US5800832A (en) | 1996-10-18 | 1998-09-01 | Virotex Corporation | Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces |
EP0842978B1 (en) | 1996-11-19 | 2002-09-25 | Kuraray Co., Ltd. | Resin composition and multilayered structure |
DE19728516C2 (en) | 1997-07-04 | 1999-11-11 | Sanol Arznei Schwarz Gmbh | TTS for administration of levonorgestrel and possibly estradiol |
US20020012694A1 (en) | 1997-09-17 | 2002-01-31 | Alfred J. Moo-Young | Transdermal administration of ment |
US7007718B2 (en) * | 1997-11-24 | 2006-03-07 | Dayco Products, Llc | Energy attenuation apparatus for a conduit conveying liquid under pressure, system incorporating same, and method of attenuating energy in a conduit |
DE19753298A1 (en) | 1997-12-01 | 1999-06-02 | Basf Ag | Process for the preparation of solid dosage forms |
US6072100A (en) | 1998-01-28 | 2000-06-06 | Johnson & Johnson Consumer Products, Inc. | Extrudable compositions for topical or transdermal drug delivery |
US6562276B1 (en) | 1998-08-20 | 2003-05-13 | Eastman Chemical Company | Process for forming a multilayer, coinjected article |
JP2003523929A (en) | 1998-10-02 | 2003-08-12 | イエナフアルム ゲーエムベーハー ウント ツェーオー. カーゲー | Use of testosterone esters and / or testosterone for producing an orally applicable bioadhesive system with a temporally controlled medicinal action |
DE19848849A1 (en) | 1998-10-22 | 2000-04-27 | Knoll Ag | Free-flowing, homogeneous spheres of active agent, e.g. drug, in auxiliary matrix, obtained by dropping molten mixture from nozzle into fluid for freezing and solidification |
JP2001058037A (en) * | 1999-08-23 | 2001-03-06 | Taiyo Elec Co Ltd | Vane attaching substrate and game machine |
US6562369B2 (en) | 1999-12-16 | 2003-05-13 | Dermatrends, Inc. | Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers |
US6638637B2 (en) | 2000-02-16 | 2003-10-28 | 3M Innovative Properties Company | Oriented multilayer polyolefin films |
JP4300382B2 (en) | 2000-03-30 | 2009-07-22 | 日本ゼオン株式会社 | Insulating material, method for manufacturing insulating material, and method for manufacturing multilayer circuit board |
US8551526B2 (en) | 2000-11-03 | 2013-10-08 | Board Of Regents, The University Of Texas System | Preparation of drug particles using evaporation precipitation into aqueous solutions |
US6682757B1 (en) * | 2000-11-16 | 2004-01-27 | Euro-Celtique, S.A. | Titratable dosage transdermal delivery system |
WO2002060411A2 (en) | 2001-01-30 | 2002-08-08 | Board Of Regents University Of Texas System | Process for production of nanoparticles and microparticles by spray freezing into liquid |
JP2002248124A (en) | 2001-02-23 | 2002-09-03 | Nitto Denko Corp | Medical plaster and first-aid sticking plaster |
US6692424B2 (en) | 2001-08-01 | 2004-02-17 | Gammerler Corporation | Rotary trimmer apparatus and method |
US6585997B2 (en) | 2001-08-16 | 2003-07-01 | Access Pharmaceuticals, Inc. | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
US20030054042A1 (en) | 2001-09-14 | 2003-03-20 | Elaine Liversidge | Stabilization of chemical compounds using nanoparticulate formulations |
AU2003240824B9 (en) * | 2002-05-31 | 2008-09-25 | University Of Mississippi | Transmucosal delivery of cannabinoids |
US20050100515A1 (en) | 2002-09-11 | 2005-05-12 | The Procter & Gamble Company | Tooth whitening products |
US20050058602A1 (en) | 2003-09-11 | 2005-03-17 | The Procter & Gamble Company | Dye composition and method for detection of demineralized lesions in teeth |
RU2356580C2 (en) | 2003-10-28 | 2009-05-27 | Новен Фармасьютикалз, Инк | Compositions and methods providing controlled drug loss and delivery within transdermal drug delivery systems |
US20050281757A1 (en) | 2004-06-17 | 2005-12-22 | Sayed Ibrahim | Oral care film |
US8465759B2 (en) * | 2006-03-24 | 2013-06-18 | Auxilium Us Holdings, Llc | Process for the preparation of a hot-melt extruded laminate |
MX2008012264A (en) * | 2006-03-24 | 2009-02-20 | Auxilium Int Holdings Inc | Stabilized compositions containing alkaline labile drugs. |
-
2007
- 2007-03-22 MX MX2008012264A patent/MX2008012264A/en active IP Right Grant
- 2007-03-22 CA CA2647809A patent/CA2647809C/en not_active Expired - Fee Related
- 2007-03-22 NZ NZ572207A patent/NZ572207A/en not_active IP Right Cessation
- 2007-03-22 EP EP07759188.1A patent/EP2010156B1/en not_active Not-in-force
- 2007-03-22 BR BRPI0709148-6A patent/BRPI0709148A2/en not_active Application Discontinuation
- 2007-03-22 EP EP16194591.0A patent/EP3141248A1/en not_active Withdrawn
- 2007-03-22 CA CA2932389A patent/CA2932389A1/en not_active Abandoned
- 2007-03-22 AU AU2007230730A patent/AU2007230730B2/en not_active Ceased
- 2007-03-22 WO PCT/US2007/064714 patent/WO2007112286A2/en active Application Filing
- 2007-03-22 JP JP2009503173A patent/JP5536446B2/en not_active Expired - Fee Related
- 2007-03-22 CN CN2007800188470A patent/CN101484142B/en not_active Expired - Fee Related
- 2007-03-22 US US12/294,367 patent/US8173152B2/en not_active Expired - Fee Related
- 2007-03-22 ES ES07759188.1T patent/ES2619906T3/en active Active
-
2008
- 2008-09-21 IL IL194222A patent/IL194222A/en not_active IP Right Cessation
- 2008-10-23 ZA ZA2008/09104A patent/ZA200809104B/en unknown
-
2012
- 2012-05-03 US US13/463,375 patent/US8883187B2/en not_active Expired - Fee Related
-
2014
- 2014-10-17 US US14/517,140 patent/US9364445B2/en not_active Expired - Fee Related
-
2016
- 2016-05-19 US US15/159,285 patent/US9867786B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6048547A (en) * | 1996-04-15 | 2000-04-11 | Seth; Pawan | Process for manufacturing solid compositions containing polyethylene oxide and an active ingredient |
US6649186B1 (en) * | 1996-09-20 | 2003-11-18 | Ethypharm | Effervescent granules and methods for their preparation |
US6375963B1 (en) * | 1999-06-16 | 2002-04-23 | Michael A. Repka | Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof |
Non-Patent Citations (1)
Title |
---|
APICELLA ET AL.: "Poly(ethylene oxide) (PEO) and Different Molecular Weight PEO Blends Monotlithic Devices for Drug Release", BIOMATERIALS, vol. 14, no. 2, 1993, pages 83 - 90, XP022751583 * |
Also Published As
Publication number | Publication date |
---|---|
US20160256405A1 (en) | 2016-09-08 |
JP2009531453A (en) | 2009-09-03 |
WO2007112286A2 (en) | 2007-10-04 |
ES2619906T3 (en) | 2017-06-27 |
CA2647809A1 (en) | 2007-10-04 |
JP5536446B2 (en) | 2014-07-02 |
CA2647809C (en) | 2016-08-16 |
US9364445B2 (en) | 2016-06-14 |
BRPI0709148A2 (en) | 2011-06-28 |
EP2010156B1 (en) | 2016-11-16 |
US20120214777A1 (en) | 2012-08-23 |
CA2932389A1 (en) | 2007-10-04 |
CN101484142B (en) | 2013-06-05 |
US8173152B2 (en) | 2012-05-08 |
NZ572207A (en) | 2012-02-24 |
IL194222A (en) | 2014-12-31 |
EP2010156A4 (en) | 2012-07-18 |
AU2007230730A1 (en) | 2007-10-04 |
EP2010156A2 (en) | 2009-01-07 |
US9867786B2 (en) | 2018-01-16 |
CN101484142A (en) | 2009-07-15 |
ZA200809104B (en) | 2010-02-24 |
EP3141248A1 (en) | 2017-03-15 |
US20090264385A1 (en) | 2009-10-22 |
US20150057259A1 (en) | 2015-02-26 |
MX2008012264A (en) | 2009-02-20 |
US8883187B2 (en) | 2014-11-11 |
AU2007230730B2 (en) | 2013-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007112286A3 (en) | Stabilized compositions containing alkaline labile drugs | |
WO2008100375A3 (en) | Polymer-based films and drug delivery systems made therefrom | |
WO2009026461A3 (en) | Thermo-kinetic mixing for pharmaceutical applications | |
WO2009132265A3 (en) | Degradable compounds and methods of use thereof, particularly with particle replication in non-wetting templates | |
WO2008005371A3 (en) | Poly(orthoester) polymers, and methods of making and using same | |
WO2010022193A3 (en) | Hot-melt extrusion of modified release multi-particulates | |
WO2006017852A3 (en) | Pharmaceutical compositions for controlled release delivery of biologically active compounds | |
DK1610768T3 (en) | Matrix compositions for controlled delivery of drug substances | |
WO2005049717A3 (en) | Polymeric compositions for sustained release of volatile materials | |
SG155880A1 (en) | Multiparticulates of preferably an opioid, and method of manufacturing using extrusion | |
WO2008122965A3 (en) | Pharmaceutical cyclosporin compositions | |
WO2006099514A3 (en) | Drug delivery compositions and related methods | |
WO2009129300A3 (en) | Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas | |
WO2007100902A3 (en) | Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation | |
WO2010002668A8 (en) | Polymeric blends and methods of using same | |
WO2007103257A3 (en) | Method of powder coating medical devices | |
WO2007014393A3 (en) | Amorphous efavirenz and the production thereof | |
WO2008063301A3 (en) | Pharmaceutical compositions | |
WO2007061828A3 (en) | Pharmaceutical compositions comprising buprenorphine | |
WO2007150075A3 (en) | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone | |
IL196426A0 (en) | Microparticulates based on an amphiphilic copolymer, processes for the preparation thereof and pharmaceutical compositions containing the same | |
PL2377396T3 (en) | Resin composition containing release-controlled agricultural chemical, production method thereof, and agricultural chemical formulation | |
WO2012015547A3 (en) | Polyamide/poly(arylene ether) composition, article, and method | |
WO2007106182A3 (en) | Process for making pharmaceutical compositions with a transient plasticizer | |
WO2009066956A3 (en) | Lyophilized pharmaceutical composition with improved reconstitution time containing taxane derivatives and method of manufacturing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780018847.0 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07759188 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 194222 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12294367 Country of ref document: US Ref document number: 2009503173 Country of ref document: JP Ref document number: 2647809 Country of ref document: CA Ref document number: MX/A/2008/012264 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 572207 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007230730 Country of ref document: AU Ref document number: 8937/DELNP/2008 Country of ref document: IN |
|
REEP | Request for entry into the european phase |
Ref document number: 2007759188 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007759188 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2007230730 Country of ref document: AU Date of ref document: 20070322 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: PI0709148 Country of ref document: BR Kind code of ref document: A2 Effective date: 20080924 |